Selected article for: "auroc curve and significant fibrosis"
Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017
  • Document date: 2017_11_7
    • ID: roslkxeq_702
    Snippet: In this validation population, the blood score discriminates dogs with significant fibrosis, with an AUROC curve of 0. The validation protocol demonstrated similar performances between the training and the validation population. The blood score developed in this study was designed to help clinicians to screen for dogs with liver fibrosis in order to guide further investigations. This test provides accurate and reliable results in a fast, simple a.....
    Document: In this validation population, the blood score discriminates dogs with significant fibrosis, with an AUROC curve of 0. The validation protocol demonstrated similar performances between the training and the validation population. The blood score developed in this study was designed to help clinicians to screen for dogs with liver fibrosis in order to guide further investigations. This test provides accurate and reliable results in a fast, simple and cost-effective manner. An external validation protocol is needed for further assessment of the robustness of the test.

    Search related documents:
    Co phrase search for related documents
    • auroc curve and clinician help: 1
    • auroc curve and external validation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • auroc curve and liver fibrosis: 1, 2
    • auroc curve and significant fibrosis: 1, 2
    • auroc curve and similar performance: 1, 2, 3, 4, 5
    • auroc curve and study develop: 1, 2, 3, 4, 5, 6, 7
    • auroc curve and validation population: 1
    • blood score and external validation: 1
    • blood score and study develop: 1, 2
    • clinician help and external validation: 1
    • clinician help and liver fibrosis: 1
    • external validation and similar performance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • external validation and study develop: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
    • external validation and validation population: 1, 2, 3, 4, 5, 6, 7, 8, 9